Navigation Links
A start-up at NJIT develops bleeding-control gel for brain surgery
Date:7/10/2014

Endomedix, a start-up company housed at NJIT's business incubator, received a $1.4 million federal grant to develop a spray-on gel that surgeons will use to staunch bleeding during brain surgery.

Surgeons can spray the gel onto a surgical site, and the natural bio-polymer solutions in the gel will cohere and control bleeding in the patient within 30 seconds.

The gel can shorten an intracranial surgery by 30- 45 minutes. It will translate into less time for the patient's skull to be open and less anesthesia, reducing both the possibility of infection and morbidity. Shorter surgeries also reduce hospital costs: The new gel is expected to save hospitals more than $3000- $4000 per case.

The National Institute of Neurological Disorders and Stroke awarded the $1.4 million grant to Endomedix to support its research on the gel, technically classified as a medical device. The institute, based at the National Institutes of Health, awards grants through a rigorous peer-review process. The institute had previously awarded an earlier grant to Endomedix for the same project.

Based at the Enterprise Development Center (EDC) http://www.njit-edc.org/, Endomedix, has been developing the gel, known as a surgical hemostat, since 2009. Its applied research phase has been successful the company has two issued U.S. patents on the gel and will begin biocompatibility testing later this year. After the tests are finished, the firm will seek regulatory authorization to begin clinical studies.

"It's exciting to push through milestones toward commercialization and bring savings to hospitals and improvement in a $4 billion surgical market," said Endomedix president and CEO Richard Russo. "Being housed in the incubator has allowed us to partner with NJIT research professors such as Michael Jaffe who lead the nation in biomedical engineering and polymer chemistry."

Having a lab in the incubator has also allowed the firm to hire NJIT graduates. A recent graduate, Piyush Modak, (2010, master's in biomedical engineering), is the manager of research and development at Endomedix, and it has hired other NJIT graduates to refine the chemical properties of the gel.

The hydrogel derives from two polysaccharides that are simultaneously mixed and sprayed onto a surgical site. Once the hydrogel is mixed, it forms an adhesive and cohesive material that gelates within 30 seconds. The hydrogel solutions are made from natural materials and do not contain and blood or tissue components. That makes them highly biocompatible.

Russo said NJIT professors and its graduates are helping his firm to develop a device -- the gel -- that will enhance medical procedures, reduce hospital costs, and most importantly, reduce infection and morbidity rates.

"The EDC incubator is a great eco-system for a start-up company because it gives us entre to NJIT research professors, to university instruments and facilities and to bright NJIT grads," said Russo. "And that eco-system supports our drive to bring our device to market and enhance the medical system."


'/>"/>
Contact: Robert Florida
robert.florida@njit.edu
201-725-6435
New Jersey Institute of Technology
Source:Eurekalert

Related biology news :

1. Wayne State University licenses technology to new start-up, Detroit Materials, Inc.
2. The Human Frontier Science Program selects new heads of start-up laboratories
3. Insect research heads down path to start-up company with NSF I-Corps program
4. NTU start-up launches worlds first 3-in-1 water monitoring system
5. Penn research develops onion vesicles for drug delivery
6. Healthy tissue grafted to the brains of Huntingtons patients also develops the disease
7. CSIC develops a software able to identify and track an specific individual within a group
8. How kids brain structures grow as memory develops
9. Gauging the impact of tropical forest logging: Winrock develops new method for quantifying carbon emissions
10. AZTI-Tecnalia develops a methodology for authenticating canned tuna species within 24 hours
11. Virginia Tech researcher develops energy-dense sugar battery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/17/2019)... ... July 15, 2019 , ... RCH ... Life Sciences and Healthcare companies, announces the availability of new specialty advisory practice, ... direction to start-up and emerging bio-pharma companies interested in achieving specific outcomes related ...
(Date:7/9/2019)... ... July 09, 2019 , ... Murrieta Genomics, a launch pad ... The founder and CEO of Tx Genetic, Helen Harrison, has spent several years ... epithelial connective tissue disorders. , “We are pleased and excited to join the ...
(Date:6/25/2019)... ... , ... ActX has launched a medical genetic interpretation ... can get access to professionally reviewed genetic screening similar to what a physician ... + Ancestry customers., With the ActX + 23andMe service, both 23andMe customers and ...
Breaking Biology News(10 mins):
(Date:7/11/2019)... LAS VEGAS (PRWEB) , ... July 11, 2019 , ... ... 2019, R3 provided complimentary regenerative therapies to eight military Veterans under the R3 Heroes ... procedures being complimentary. , The R3 Heroes Program allow anyone to nominate a military ...
(Date:7/9/2019)... ... July 08, 2019 , ... Balluff has been named a ... the 2019 Innovative Product of the Year which highlights cutting-edge advancements and achievements ... Sensors Expo & Conference 2019, held this week in San Jose, California. ...
(Date:6/26/2019)... ... ... Alice Branton today released research results from preclinical trials on the beneficial impact ... to be beneficial for treating Hypomagnesemia. , The preclinical trial shows:, ... Over 142% increase in particle size , Over 3% alteration ...
(Date:6/18/2019)... ... 2019 , ... Personalized Stem Cells, Inc (“PSC”), a human adipose-derived ... for use of a person’s own adipose-derived stem cells to treat their osteoarthritis. The ... This IND is the first of several planned clinical trials which will enable ...
Breaking Biology Technology: